| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Marbofloxacin
|
115550-35-1 |
马波沙星
|
马波沙星;马波沙星 1G;麻保沙星溶液,100PPM;马波沙星溶液,1000PPM;麻保沙星/马波沙星;麻保沙星溶液,1000PPM;麻保沙星标准品;马波沙星标准品
|
C17H19N4O4F |
362.36 | 640-416-5 |
|
Capecitabine impurity D
|
910129-15-6 |
5'-脱氧- 5 -氟-N -[(2-甲基丁)羰基]胞苷
|
CS-936;CAPECITABINE-4;卡培他滨杂质2;5'-脱氧-5-氟-N-[(2-甲基丁)羰基]胞苷;卡培他滨杂质E;5'-脱氧-5-氟-N-[(2-甲基丁氧基)羰基]胞苷;卡培他滨USP杂质E;卡培他滨EP杂质D
|
C15H22FN3O6 |
359.350083 | |
|
Capecitabine impurity F
|
162204-30-0 |
5'-脱氧- 5 -氟-N -[(3-甲基丁)羰基]胞苷
|
5'-脱氧-5-氟-N4-(3-甲基-1);5'-脱氧-5-氟-N-[(3-甲基丁)羰基]胞苷;卡培他滨杂质E;5'-脱氧-5-氟-N4-(3-甲基-1);CAPECITABINE-3;卡培他滨杂质3;5'-脱氧-5-氟-N-[(3-甲基丁)羰基]胞苷;卡培他滨杂质F;5'-脱氧-5-氟-N-[(3-甲基丁氧基)羰基]胞苷
|
C15H22 F N3 O6 |
359.3500832 | |
|
LY 303511
|
154447-38-8 |
8-苯基-2-(1-哌嗪基)-4H-1-苯并吡喃-4-酮
|
LY 303511;LY303511;8-苯基-2-(1-哌嗪基)-4H-1-苯并吡喃-4-酮
|
C19H18N2O2 |
306.363 | |
|
PA-824
|
187235-37-6 |
(S)-6,7-二氢-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]恶嗪
|
PA-824;PA824;PA 824;(S)-6,7-二氢-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]恶嗪;PRETOMANID;PA824(S)-6,3]恶嗪;2-NITRO-6(S)-[4-(TRIFLUOROMETHOXY)BENZYLOXY]-6,7-DIHYDRO-5H-IMIDAZO[2,3]OXAZINE;PRETOMANID;(S)-PA 824
|
C14H12F3N3O5 |
359.2573896 | 1533716-785-6 |
|
B-Raf-inhibitor 1
|
1093100-40-3 |
N1-(4-氯苯基)-6-甲基-N5-[3-(9H-嘌呤-6-基)-2-吡啶]-1,5-异喹啉二胺
|
N1-(4-氯苯基)-6-甲基-N5-[3-(9H-嘌呤-6-基)-2-吡啶]-1,5-异喹啉二胺;N1-(4-氯苯基)-6-甲基-N5-[3-(9H-嘌呤-6-基)-2-吡啶基]-1,5-异喹啉二胺;CS-927
|
C26H19ClN8 |
478.93566 | |
|
Trelagliptin succinate-SYR 111472 succinate
|
1029877-94-8 |
琥珀酸曲格列汀
|
曲格列汀2;曲格列汀琥珀酸;2-[[6-[(3R)-3-氨基-1-哌啶基]-3,4-二氢-3-甲基-2,4-二氧代-1(2H)-嘧啶基]甲基]-4-氟-苯甲腈琥珀酸盐;-[[2'-(2,5-二氢-5-氧代-1,2,4-恶二唑-3-基)[1,1'-联苯]-4-基]甲基]-2-乙氧基-1H-苯并咪唑-7-羧酸 (5-甲基;(R)-2-[[2,4-二氧代-3-甲基-6-(3-氨基-1-哌啶基)-1,3,4-四氢-1-嘧啶基]甲基]-4-氟苯腈琥珀酸盐;曲格列汀琥珀酸盐
|
C22H26FN5O6 |
475.4701432 | |
|
1 NM-PP1
|
221244-14-0 |
4-氨基1-叔丁基-3-(1'-萘甲基)吡唑并[3,4-D]嘧啶
|
4-氨基1-叔丁基-3-(1'-萘甲基)吡唑并[3,4-D]嘧啶;CS-920
|
C20H21N5 |
331.41 | |
|
(-)-Huperzine A
|
102518-79-6 |
石杉碱甲
|
石衫碱甲;石杉碱甲;石山碱甲;石杉碱甲HUPERZINE-A;石杉碱甲(标准品);(-)-石杉碱甲;(5R,9R,11E)-5-氨基-11-乙叉基-5,6,9,10-四氢-7-甲基-5,9-甲撑环辛并(B)吡啶-2(1H)酮;石杉碱钾A
|
C15H18N2O |
242.32 | 600-320-6 |
|
TG02
|
937270-47-8 |
14-甲基-2-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,1,12(26),16,21,23-十烯
|
14-甲基-20-氧杂-5,7,14,27-四氮杂四环[19.3.1.1(2,6).1(8,12)]二十七碳-1(25),2,4,6(27),8,10,12(26),16,21,23-十烯;CS-915;TG02;SB 1317;TG 02;SB-1317;TG-02;TG02;TG-02
|
C23H24N4O |
372.5 | |
|
RI-1
|
415713-60-9 |
3-氯-1-(3,4-二氯苯基)-4-(4-吗啉基)-1H-吡咯-2,5-二酮
|
3-氯-1-(3,4-二氯苯基)-4-(4-吗啉基)-1H-吡咯-2,5-二酮;13-氯-1-(3;RI1;RI-1;4-二氯苯基)-4-(4-吗啉基)-1H-吡咯-2
|
C14H11Cl3N2O3 |
361.60774 | |
|
A-966492
|
934162-61-5 |
2-[2-氟-4-[(2S)-2-吡咯烷基]苯基]-1H-苯并咪唑-7-甲酰胺
|
2-[2-氟-4-[(2S)-2-吡咯烷基]苯基]-1H-苯并咪唑-7-甲酰胺;A966492;A 966492;A-966492;CS-903
|
C18H17FN4O |
324.36 | |
|
N4-(4-Phenoxyphenethyl)quinazoline-4,6-diamine
|
545380-34-5 |
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺
|
QNZ (EVP4593);EVP-4593;6-氨基-4-(4-苯氧基苯基乙基氨基)喹唑啉;CS-902;EVP4593;EVP 4593;EVP-4593;N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺
|
C22H20N4O |
356.42 | |
|
N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea
|
1057249-41-8 |
N-(3-氯苯基)-N'-[5-[2-(噻吩并[3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲
|
SNS314;SNS 314;CS-901;N-(3-氯苯基)-N'-[5-[2-(噻吩并[3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲
|
C18H15ClN6OS2 |
430.9343 | |
|
LY2608204
|
1234703-40-2 |
(1R,2S)-2-环己基-1-[4-(环丙基磺酰基)苯基]-N-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]环丙烷甲酰胺
|
(1R,2S)-2-环己基-1-[4-(环丙基磺酰基)苯基]-N-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]环丙烷甲酰胺;LY-2608204;LY 2608204;CS-898;1R,2S)-2-环己基-1-(4-(环丙基磺酰基)苯基)-N-(5-((2-(吡咯烷-1-基)乙基)硫代)噻唑-2-基)环丙烷羧酰胺;LY2608204 (1R,2S)-2-环己基-1-(4-(环丙基磺酰基)苯基)-N-(5-((2-(吡咯烷-1-基)乙基)硫代)噻唑-2-基)环丙烷羧酰胺
|
C28H37N3O3S3 |
559.80668 | |
|
Emtricitabine
|
143491-57-0 |
恩曲他滨
|
维生素E杂质;盐酸恩曲他滨;恩去他滨;恩曲他滨 EMTRIVA;恩曲他滨 EMTRICITABINE;恩曲他滨(标准品);恩曲他滨(5-氟-1-(2R,5S)-[2-羟甲基-1,3-氧硫环-6-酰]胞嘧啶)
|
C8H10FN3O3S |
247.25 | |
|
4-[3-Oxo-3-(2-oxo-2,3-dihydrobenzoxazol-6-yl)propyl]piperazine-1-carboxylic acid 3,5-dichlorobenzyl ester
|
1144035-53-9 |
4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯
|
PF-8380 HCL;4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯;PF 8380;PF8380;CS-894;PF-8380;PF 8380;PF8380
|
C22H21Cl2N3O5 |
478.32524 | |
|
KU14R
|
189224-48-4 |
2-(2-乙基-2,3-二氢-2-苯并呋喃基)-1H-咪唑
|
2-(2-乙基-2,3-二氢-2-苯并呋喃基)-1H-咪唑;KU-14R;KU 14R;CS-891
|
C13H14N2O |
214.26 | |
|
NSC 42834
|
195371-52-9 |
2-METHYL-1-PHENYL-4-(PYRIDIN-2-YL)-2-(2-(PYRIDIN-2-YL)ETHYL)BUTAN-1-ONE
|
2-METHYL-1-PHENYL-4-(2-PYRIDINYL)-2-[2-(2-PYRIDINYL)ETHYL]-;NSC 42834 (JAK2 INHIBITOR V);2-METHYL-1-PHENYL-4-(PYRIDIN-2-YL)-2-(2-(PYRIDIN-2-YL)ETHYL)BUTAN-1-ONE;2-甲基-1-苯基-4-(2-吡啶基)-2-[2-(2-吡啶基)乙基]-1-丁酮
|
C23H24N2O |
344.44946 | |
|
Docetaxel
|
125354-16-7 |
多西他赛
|
多西他赛EP杂质G(10-乙酰多西他赛);多西他赛EP杂质G;三水多西他赛;多西他赛、多西他赛;多西紫杉醇杂质;多烯紫杉醇,98%;10-乙酰多西他赛;紫杉醇杂质3
|
C45H55NO15 |
849.9159 | 1533716-785-6 |







